(Reuters) - The company, which makes and markets over-the-counter drugs, toiletries and cosmetics, said its net income was $14.9 million, or 77 cents a share, compared with $10.2 million, or 52 cents a share a year ago.
Excluding stock-compensation expense and other items, second-quarter net income rose 56 percent to $17.3 million, or 89 cents a share.
Read more at Reuters.com Market News
Excluding stock-compensation expense and other items, second-quarter net income rose 56 percent to $17.3 million, or 89 cents a share.
Read more at Reuters.com Market News
No comments:
Post a Comment